About
Latica-Med is a medical devices company, focused on developing novel therapies designed to transform the standard of care for Gynecology and other diseases with the aim to improve women fertility by non-invasive, non-drug therapy.
Latica owns a proprietary patented Acoustic Pulse Technology (APT) device specifically designed for treating Gynecology disorders. APT as a shockwave have been widely reported over the last 20 years for treating patients with inflammatory, ischemic diseases treatment devices. Latica's APT is a compact, cost-effective device, specially designed for treatments on a large treatment area (50x350 mm), which can open an opportunity for Gynecology treatments in a short time.
Latica uses its innovative acoustic pulses technology (APT) to prepare women for the delicate IVF process, by treating most of the root-causes of infertility, including: Infections, implantation failures, endometrium thickness and Endometriosis. The company's pre-clinical trial showed a 60% improvement in pregnanc
Funding history · 1 round · $200K total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Latica Med's primary focus?
- Latica Med is a medical devices company focused on developing novel therapies to transform the standard of care for Gynecology and other diseases, aiming to improve women's fertility through non-invasive, non-drug therapy.
- When was Latica Med founded?
- Latica Med was founded in June 2023.
- What proprietary technology does Latica Med utilize?
- Latica Med owns a proprietary patented Acoustic Pulse Technology (APT) device specifically designed for treating Gynecology disorders.
- What is the current employee count for Latica Med?
- Latica Med currently has 4 employees.
- What was Latica Med's most recent funding round?
- In April 2024, Latica Med completed a Pre-Seed funding round, raising a total of $200,000. PipelBiz was an investor in this round.
- What is the product stage of Latica Med's technology?
- Latica Med's product, Lati-A, is currently in the clinical trial stage.
- What are Latica Med's plans regarding clinical trials?
- According to startupim data, Latica Med is set to commence a clinical trial soon to enhance IVF success rates, as of March 2025.
- Who are the founders of Latica Med?
- The founders of Latica Med are Eduard Papirov, Itzhak Fridman, and Sari Prutchi-Sagiv.